Terumo and Kyoto’s Center for CiRA advance on production of erythrocyte progenitor cells from human embryonic stem cells, big step forward towards artificial erythrocytes.

POTENTIAL APPLICATION OF AN IMMORTALIZED ERYTHROCYTE-PRODUCING CELL LINE DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
Sho-ichi Hirose, Terumo Corporation, Japan
ISSCR 10th Annual Meeting will be held June 13 – 16, 2012

Sho-ichi Hirose, Terumo Corporation, ISSCR 10th Annual Meeting June 13 – 16, 2012

Terumo and Kyoto’s Center for CiRA advance on production of erythrocyte progenitor cells from human embryonic stem cells, big step forward towards artificial erythrocytes.
Scroll to top